http://www.stockbloghub.com Start Your Investing Research Here! Wed, 22 May 2013 17:44:23 +0000 en-US hourly 1 http://wordpress.org/?v=3.5.1 http://www.stockbloghub.com/2013/05/16/gsk-glaxosmithklines-trametinib-delayed/135349 http://www.stockbloghub.com/2013/05/16/gsk-glaxosmithklines-trametinib-delayed/135349#comments Thu, 16 May 2013 20:33:46 +0000 vitalstocks http://www.stockbloghub.com/?p=135349 http://www.stockbloghub.com/2013/05/16/gsk-glaxosmithklines-trametinib-delayed/135349/feed 0 http://www.stockbloghub.com/2013/05/15/ipxl-impax-laboratories-beats-earnings-estimate/135175 http://www.stockbloghub.com/2013/05/15/ipxl-impax-laboratories-beats-earnings-estimate/135175#comments Wed, 15 May 2013 16:45:02 +0000 vitalstocks http://www.stockbloghub.com/?p=135175 http://www.stockbloghub.com/2013/05/15/ipxl-impax-laboratories-beats-earnings-estimate/135175/feed 0 http://www.stockbloghub.com/2013/04/27/nvs-theravance-glaxo-drug-to-face-fda-panel/133837 http://www.stockbloghub.com/2013/04/27/nvs-theravance-glaxo-drug-to-face-fda-panel/133837#comments Sat, 27 Apr 2013 23:11:07 +0000 vitalstocks http://www.stockbloghub.com/?p=133837 http://www.stockbloghub.com/2013/04/27/nvs-theravance-glaxo-drug-to-face-fda-panel/133837/feed 0 http://www.stockbloghub.com/2013/04/18/gsk-glaxosmithklines-flu-vaccine-approved/132801 http://www.stockbloghub.com/2013/04/18/gsk-glaxosmithklines-flu-vaccine-approved/132801#comments Thu, 18 Apr 2013 20:37:10 +0000 vitalstocks http://www.stockbloghub.com/?p=132801 http://www.stockbloghub.com/2013/04/18/gsk-glaxosmithklines-flu-vaccine-approved/132801/feed 0 http://www.stockbloghub.com/2013/04/07/mrk-pharma-biotech-stock-outlook-apr-2013-zacks-analyst-interviews/132525 http://www.stockbloghub.com/2013/04/07/mrk-pharma-biotech-stock-outlook-apr-2013-zacks-analyst-interviews/132525#comments Sun, 07 Apr 2013 18:52:57 +0000 vitalstocks http://www.stockbloghub.com/?p=132525 http://www.stockbloghub.com/2013/04/07/mrk-pharma-biotech-stock-outlook-apr-2013-zacks-analyst-interviews/132525/feed 0 http://www.stockbloghub.com/2013/01/31/jnj-medtech-industry-stock-outlook-january-2013-zacks-analyst-interviews/127562 http://www.stockbloghub.com/2013/01/31/jnj-medtech-industry-stock-outlook-january-2013-zacks-analyst-interviews/127562#comments Thu, 31 Jan 2013 19:55:35 +0000 Shawn http://www.stockbloghub.com/?p=127562 http://www.stockbloghub.com/2013/01/31/jnj-medtech-industry-stock-outlook-january-2013-zacks-analyst-interviews/127562/feed 0 http://www.stockbloghub.com/2013/01/16/gsk-glaxosmithkline-and-theravance-seek-european-approval/125979 http://www.stockbloghub.com/2013/01/16/gsk-glaxosmithkline-and-theravance-seek-european-approval/125979#comments Wed, 16 Jan 2013 15:53:07 +0000 Shawn http://www.stockbloghub.com/?p=125979 http://www.stockbloghub.com/2013/01/16/gsk-glaxosmithkline-and-theravance-seek-european-approval/125979/feed 0 http://www.stockbloghub.com/2013/01/15/xoma-xomas-gevokizumab-study-update/126279 http://www.stockbloghub.com/2013/01/15/xoma-xomas-gevokizumab-study-update/126279#comments Tue, 15 Jan 2013 22:52:06 +0000 Shawn http://www.stockbloghub.com/?p=126279 http://www.stockbloghub.com/2013/01/15/xoma-xomas-gevokizumab-study-update/126279/feed 0 http://www.stockbloghub.com/2013/01/09/alny-alnylam-pharmaceuticals-provides-pipeline-update/125786 http://www.stockbloghub.com/2013/01/09/alny-alnylam-pharmaceuticals-provides-pipeline-update/125786#comments Wed, 09 Jan 2013 20:35:20 +0000 Shawn http://www.stockbloghub.com/?p=125786 http://www.stockbloghub.com/2013/01/09/alny-alnylam-pharmaceuticals-provides-pipeline-update/125786/feed 0 http://www.stockbloghub.com/2012/12/28/gsk-glaxosmithklines-influenza-vaccine-approved/124498 http://www.stockbloghub.com/2012/12/28/gsk-glaxosmithklines-influenza-vaccine-approved/124498#comments Fri, 28 Dec 2012 16:03:41 +0000 Shawn http://www.stockbloghub.com/?p=124498 http://www.stockbloghub.com/2012/12/28/gsk-glaxosmithklines-influenza-vaccine-approved/124498/feed 0 http://www.stockbloghub.com/2012/12/23/gsk-glaxosmithkline-anthrax-drug-gets-fda-nod/124132 http://www.stockbloghub.com/2012/12/23/gsk-glaxosmithkline-anthrax-drug-gets-fda-nod/124132#comments Sun, 23 Dec 2012 16:44:18 +0000 Shawn http://www.stockbloghub.com/?p=124132 http://www.stockbloghub.com/2012/12/23/gsk-glaxosmithkline-anthrax-drug-gets-fda-nod/124132/feed 0 http://www.stockbloghub.com/2012/12/19/chmp-isis-pharmaceuticals-kynamro-earns-negative-report-from-european-medicines-agency/123918 http://www.stockbloghub.com/2012/12/19/chmp-isis-pharmaceuticals-kynamro-earns-negative-report-from-european-medicines-agency/123918#comments Wed, 19 Dec 2012 17:54:05 +0000 Shawn http://www.stockbloghub.com/?p=123918 http://www.stockbloghub.com/2012/12/19/chmp-isis-pharmaceuticals-kynamro-earns-negative-report-from-european-medicines-agency/123918/feed 0 http://www.stockbloghub.com/2012/12/16/isis-isis-pharmaceuticals-and-astrazeneca-ink-deal/123605 http://www.stockbloghub.com/2012/12/16/isis-isis-pharmaceuticals-and-astrazeneca-ink-deal/123605#comments Mon, 17 Dec 2012 03:43:11 +0000 Shawn http://www.stockbloghub.com/?p=123605 http://www.stockbloghub.com/2012/12/16/isis-isis-pharmaceuticals-and-astrazeneca-ink-deal/123605/feed 0 http://www.stockbloghub.com/2012/12/07/mrk-pharmaceuticals-and-biotech-stock-outlook-december-2012-industry-outlook/122969 http://www.stockbloghub.com/2012/12/07/mrk-pharmaceuticals-and-biotech-stock-outlook-december-2012-industry-outlook/122969#comments Fri, 07 Dec 2012 22:19:05 +0000 vitalstocks http://www.stockbloghub.com/?p=122969 http://www.stockbloghub.com/2012/12/07/mrk-pharmaceuticals-and-biotech-stock-outlook-december-2012-industry-outlook/122969/feed 0 http://www.stockbloghub.com/2012/11/24/vrtx-vertex-pharmaceuticals-posts-disappointing-quarter/119293 http://www.stockbloghub.com/2012/11/24/vrtx-vertex-pharmaceuticals-posts-disappointing-quarter/119293#comments Sat, 24 Nov 2012 16:23:17 +0000 vitalstocks http://www.stockbloghub.com/?p=119293 http://www.stockbloghub.com/2012/11/24/vrtx-vertex-pharmaceuticals-posts-disappointing-quarter/119293/feed 0 http://www.stockbloghub.com/2012/10/23/are-alexandria-real-estate-equities-pens-new-lease-deals/115769 http://www.stockbloghub.com/2012/10/23/are-alexandria-real-estate-equities-pens-new-lease-deals/115769#comments Tue, 23 Oct 2012 15:09:32 +0000 vitalstocks http://www.stockbloghub.com/?p=115769 http://www.stockbloghub.com/2012/10/23/are-alexandria-real-estate-equities-pens-new-lease-deals/115769/feed 0 http://www.stockbloghub.com/2012/10/23/arna-arena-pharmaceuticals-initiates-pah-study/116371 http://www.stockbloghub.com/2012/10/23/arna-arena-pharmaceuticals-initiates-pah-study/116371#comments Tue, 23 Oct 2012 14:52:35 +0000 vitalstocks http://www.stockbloghub.com/?p=116371 http://www.stockbloghub.com/2012/10/23/arna-arena-pharmaceuticals-initiates-pah-study/116371/feed 0 http://www.stockbloghub.com/2012/10/20/wpi-watson-pharmaceuticals-a-step-closer-to-actavis/117204 http://www.stockbloghub.com/2012/10/20/wpi-watson-pharmaceuticals-a-step-closer-to-actavis/117204#comments Sat, 20 Oct 2012 19:44:56 +0000 vitalstocks http://www.stockbloghub.com/?p=117204 http://www.stockbloghub.com/2012/10/20/wpi-watson-pharmaceuticals-a-step-closer-to-actavis/117204/feed 0 http://www.stockbloghub.com/2012/10/16/gsk-glaxosmithkline-gets-encouraging-data-on-cancer-drug/115352 http://www.stockbloghub.com/2012/10/16/gsk-glaxosmithkline-gets-encouraging-data-on-cancer-drug/115352#comments Tue, 16 Oct 2012 22:11:23 +0000 vitalstocks http://www.stockbloghub.com/?p=115352 http://www.stockbloghub.com/2012/10/16/gsk-glaxosmithkline-gets-encouraging-data-on-cancer-drug/115352/feed 0 http://www.stockbloghub.com/2012/10/14/isis-isis-pharmaceuticals-owns-18-of-regulus/116015 http://www.stockbloghub.com/2012/10/14/isis-isis-pharmaceuticals-owns-18-of-regulus/116015#comments Sun, 14 Oct 2012 20:36:01 +0000 vitalstocks http://www.stockbloghub.com/?p=116015 http://www.stockbloghub.com/2012/10/14/isis-isis-pharmaceuticals-owns-18-of-regulus/116015/feed 0 http://www.stockbloghub.com/2012/10/09/thrx-theravance-stays-neutral/115347 http://www.stockbloghub.com/2012/10/09/thrx-theravance-stays-neutral/115347#comments Wed, 10 Oct 2012 04:19:07 +0000 vitalstocks http://www.stockbloghub.com/?p=115347 http://www.stockbloghub.com/2012/10/09/thrx-theravance-stays-neutral/115347/feed 0 http://www.stockbloghub.com/2012/10/09/rdy-generic-launch-at-dr-reddys-laboratories/114557 http://www.stockbloghub.com/2012/10/09/rdy-generic-launch-at-dr-reddys-laboratories/114557#comments Wed, 10 Oct 2012 03:54:57 +0000 vitalstocks http://www.stockbloghub.com/?p=114557 http://www.stockbloghub.com/2012/10/09/rdy-generic-launch-at-dr-reddys-laboratories/114557/feed 0 http://www.stockbloghub.com/2012/10/09/lly-eli-lilly-and-companys-cialis-gets-opinion-from-committee-for-medicinal-products-for-human-use/113747 http://www.stockbloghub.com/2012/10/09/lly-eli-lilly-and-companys-cialis-gets-opinion-from-committee-for-medicinal-products-for-human-use/113747#comments Tue, 09 Oct 2012 18:50:11 +0000 vitalstocks http://www.stockbloghub.com/?p=113747 http://www.stockbloghub.com/2012/10/09/lly-eli-lilly-and-companys-cialis-gets-opinion-from-committee-for-medicinal-products-for-human-use/113747/feed 0 http://www.stockbloghub.com/2012/10/09/life-life-technologies-partners-with-bristol-myers/113015 http://www.stockbloghub.com/2012/10/09/life-life-technologies-partners-with-bristol-myers/113015#comments Tue, 09 Oct 2012 18:26:15 +0000 vitalstocks http://www.stockbloghub.com/?p=113015 http://www.stockbloghub.com/2012/10/09/life-life-technologies-partners-with-bristol-myers/113015/feed 0 http://www.stockbloghub.com/2012/10/09/gsk-glaxosmithkline-increases-stake-in-response-genetics/113031 http://www.stockbloghub.com/2012/10/09/gsk-glaxosmithkline-increases-stake-in-response-genetics/113031#comments Tue, 09 Oct 2012 18:24:09 +0000 vitalstocks http://www.stockbloghub.com/?p=113031 http://www.stockbloghub.com/2012/10/09/gsk-glaxosmithkline-increases-stake-in-response-genetics/113031/feed 0 http://www.stockbloghub.com/2012/10/09/lci-lannets-generic-fioricet-approved/113037 http://www.stockbloghub.com/2012/10/09/lci-lannets-generic-fioricet-approved/113037#comments Tue, 09 Oct 2012 18:23:46 +0000 vitalstocks http://www.stockbloghub.com/?p=113037 http://www.stockbloghub.com/2012/10/09/lci-lannets-generic-fioricet-approved/113037/feed 0 http://www.stockbloghub.com/2012/10/08/abt-abbott-laboratories-astellas-pharma-global-development-collaborate/112583 http://www.stockbloghub.com/2012/10/08/abt-abbott-laboratories-astellas-pharma-global-development-collaborate/112583#comments Mon, 08 Oct 2012 21:53:58 +0000 vitalstocks http://www.stockbloghub.com/?p=112583 http://www.stockbloghub.com/2012/10/08/abt-abbott-laboratories-astellas-pharma-global-development-collaborate/112583/feed 0 http://www.stockbloghub.com/2012/10/08/alny-alnylam-pharmaceuticals-and-isis-pharmaceuticals-venture-prices-ipo/115149 http://www.stockbloghub.com/2012/10/08/alny-alnylam-pharmaceuticals-and-isis-pharmaceuticals-venture-prices-ipo/115149#comments Mon, 08 Oct 2012 21:24:35 +0000 vitalstocks http://www.stockbloghub.com/?p=115149 http://www.stockbloghub.com/2012/10/08/alny-alnylam-pharmaceuticals-and-isis-pharmaceuticals-venture-prices-ipo/115149/feed 0 http://www.stockbloghub.com/2012/10/04/snn-medtech-industry-stock-outlook-october-2012-zacks-analyst-interviews/114835 http://www.stockbloghub.com/2012/10/04/snn-medtech-industry-stock-outlook-october-2012-zacks-analyst-interviews/114835#comments Thu, 04 Oct 2012 22:43:14 +0000 vitalstocks http://www.stockbloghub.com/?p=114835 http://www.stockbloghub.com/2012/10/04/snn-medtech-industry-stock-outlook-october-2012-zacks-analyst-interviews/114835/feed 0 http://www.stockbloghub.com/2012/09/13/rdy-dr-reddys-laboratories-launches-generic-toprol/112314 http://www.stockbloghub.com/2012/09/13/rdy-dr-reddys-laboratories-launches-generic-toprol/112314#comments Thu, 13 Sep 2012 17:00:15 +0000 vitalstocks http://www.stockbloghub.com/?p=112314 http://www.stockbloghub.com/2012/09/13/rdy-dr-reddys-laboratories-launches-generic-toprol/112314/feed 0 http://www.stockbloghub.com/2012/08/28/gsk-glaxosmithkline-johnson-johnson-candidate-in-phase-iii/110225 http://www.stockbloghub.com/2012/08/28/gsk-glaxosmithkline-johnson-johnson-candidate-in-phase-iii/110225#comments Tue, 28 Aug 2012 20:21:32 +0000 vitalstocks http://www.stockbloghub.com/?p=110225 http://www.stockbloghub.com/2012/08/28/gsk-glaxosmithkline-johnson-johnson-candidate-in-phase-iii/110225/feed 0 http://www.stockbloghub.com/2012/08/28/alnylam-pharmaceuticals-and-isis-pharmaceuticals-creation-regulus-therapeutics-to-go-public/109723 http://www.stockbloghub.com/2012/08/28/alnylam-pharmaceuticals-and-isis-pharmaceuticals-creation-regulus-therapeutics-to-go-public/109723#comments Tue, 28 Aug 2012 14:21:58 +0000 vitalstocks http://www.stockbloghub.com/?p=109723 http://www.stockbloghub.com/2012/08/28/alnylam-pharmaceuticals-and-isis-pharmaceuticals-creation-regulus-therapeutics-to-go-public/109723/feed 0 http://www.stockbloghub.com/2012/08/26/mnov-medicinovas-mn-221-yields-positive-data/110239 http://www.stockbloghub.com/2012/08/26/mnov-medicinovas-mn-221-yields-positive-data/110239#comments Sun, 26 Aug 2012 22:01:43 +0000 vitalstocks http://www.stockbloghub.com/?p=110239 http://www.stockbloghub.com/2012/08/26/mnov-medicinovas-mn-221-yields-positive-data/110239/feed 0 http://www.stockbloghub.com/2012/08/22/isis-isis-pharmaceuticals-loss-down-on-higher-revenues/108012 http://www.stockbloghub.com/2012/08/22/isis-isis-pharmaceuticals-loss-down-on-higher-revenues/108012#comments Wed, 22 Aug 2012 18:34:30 +0000 vitalstocks http://www.stockbloghub.com/?p=108012 http://www.stockbloghub.com/2012/08/22/isis-isis-pharmaceuticals-loss-down-on-higher-revenues/108012/feed 0 http://www.stockbloghub.com/2012/08/22/vvus-vivus-reports-wider-than-expected-loss/108064 http://www.stockbloghub.com/2012/08/22/vvus-vivus-reports-wider-than-expected-loss/108064#comments Wed, 22 Aug 2012 18:33:06 +0000 vitalstocks http://www.stockbloghub.com/?p=108064 http://www.stockbloghub.com/2012/08/22/vvus-vivus-reports-wider-than-expected-loss/108064/feed 0 http://www.stockbloghub.com/2012/08/21/alny-alnylam-pharmaceuticals-earns-milestone-payment/107691 http://www.stockbloghub.com/2012/08/21/alny-alnylam-pharmaceuticals-earns-milestone-payment/107691#comments Tue, 21 Aug 2012 21:11:00 +0000 vitalstocks http://www.stockbloghub.com/?p=107691 http://www.stockbloghub.com/2012/08/21/alny-alnylam-pharmaceuticals-earns-milestone-payment/107691/feed 0 http://www.stockbloghub.com/2012/08/21/prx-par-pharmaceuticals-companies-to-be-aquired-by-tpg/104812 http://www.stockbloghub.com/2012/08/21/prx-par-pharmaceuticals-companies-to-be-aquired-by-tpg/104812#comments Tue, 21 Aug 2012 18:36:39 +0000 vitalstocks http://www.stockbloghub.com/?p=104812 http://www.stockbloghub.com/2012/08/21/prx-par-pharmaceuticals-companies-to-be-aquired-by-tpg/104812/feed 0 http://www.stockbloghub.com/2012/08/20/biib-biogen-idec-inks-deal-with-regulus/108698 http://www.stockbloghub.com/2012/08/20/biib-biogen-idec-inks-deal-with-regulus/108698#comments Mon, 20 Aug 2012 15:05:00 +0000 vitalstocks http://www.stockbloghub.com/?p=108698 http://www.stockbloghub.com/2012/08/20/biib-biogen-idec-inks-deal-with-regulus/108698/feed 0 http://www.stockbloghub.com/2012/08/10/pfe-pharma-biotech-stock-outlook-august-2012-industry-outlook/108031 http://www.stockbloghub.com/2012/08/10/pfe-pharma-biotech-stock-outlook-august-2012-industry-outlook/108031#comments Fri, 10 Aug 2012 18:00:38 +0000 vitalstocks http://www.stockbloghub.com/?p=108031 http://www.stockbloghub.com/2012/08/10/pfe-pharma-biotech-stock-outlook-august-2012-industry-outlook/108031/feed 0 http://www.stockbloghub.com/2012/08/02/gsk-glaxosmithkline-plc-bear-of-the-day/107018 http://www.stockbloghub.com/2012/08/02/gsk-glaxosmithkline-plc-bear-of-the-day/107018#comments Thu, 02 Aug 2012 14:58:57 +0000 vitalstocks http://www.stockbloghub.com/?p=107018 http://www.stockbloghub.com/2012/08/02/gsk-glaxosmithkline-plc-bear-of-the-day/107018/feed 0 http://www.stockbloghub.com/2012/07/13/nymx-nymox-pharmaceutical-sees-pipeline-progress/104471 http://www.stockbloghub.com/2012/07/13/nymx-nymox-pharmaceutical-sees-pipeline-progress/104471#comments Fri, 13 Jul 2012 18:04:13 +0000 vitalstocks http://www.stockbloghub.com/?p=104471 http://www.stockbloghub.com/2012/07/13/nymx-nymox-pharmaceutical-sees-pipeline-progress/104471/feed 0 http://www.stockbloghub.com/2012/07/12/thrx-theravance-gets-positive-data-on-drug-candidate/104374 http://www.stockbloghub.com/2012/07/12/thrx-theravance-gets-positive-data-on-drug-candidate/104374#comments Thu, 12 Jul 2012 15:18:23 +0000 vitalstocks http://www.stockbloghub.com/?p=104374 http://www.stockbloghub.com/2012/07/12/thrx-theravance-gets-positive-data-on-drug-candidate/104374/feed 0 http://www.stockbloghub.com/2012/06/12/gsk-glaxosmithkline-set-to-acquire-cellzome/100302 http://www.stockbloghub.com/2012/06/12/gsk-glaxosmithkline-set-to-acquire-cellzome/100302#comments Tue, 12 Jun 2012 18:44:59 +0000 vitalstocks http://www.stockbloghub.com/?p=100302 http://www.stockbloghub.com/2012/06/12/gsk-glaxosmithkline-set-to-acquire-cellzome/100302/feed 0 http://www.stockbloghub.com/2012/06/10/are-alexandria-real-estate-equities-sees-new-lease-agreements/101717 http://www.stockbloghub.com/2012/06/10/are-alexandria-real-estate-equities-sees-new-lease-agreements/101717#comments Sun, 10 Jun 2012 19:01:24 +0000 vitalstocks http://www.stockbloghub.com/?p=101717 http://www.stockbloghub.com/2012/06/10/are-alexandria-real-estate-equities-sees-new-lease-agreements/101717/feed 0 http://www.stockbloghub.com/2012/06/04/sny-isis-pharmaceuticals-gets-standard-review-for-kynamro/101090 http://www.stockbloghub.com/2012/06/04/sny-isis-pharmaceuticals-gets-standard-review-for-kynamro/101090#comments Mon, 04 Jun 2012 16:32:12 +0000 vitalstocks http://www.stockbloghub.com/?p=101090 http://www.stockbloghub.com/2012/06/04/sny-isis-pharmaceuticals-gets-standard-review-for-kynamro/101090/feed 0 http://www.stockbloghub.com/2012/05/28/lly-eli-lilly-and-company-glp-1-agonist-delivers/100867 http://www.stockbloghub.com/2012/05/28/lly-eli-lilly-and-company-glp-1-agonist-delivers/100867#comments Mon, 28 May 2012 14:41:11 +0000 vitalstocks http://www.stockbloghub.com/?p=100867 http://www.stockbloghub.com/2012/05/28/lly-eli-lilly-and-company-glp-1-agonist-delivers/100867/feed 0 http://www.stockbloghub.com/2012/04/02/hgsi-human-genome-sciences-analyst-still-neutral-on-shares/97209 http://www.stockbloghub.com/2012/04/02/hgsi-human-genome-sciences-analyst-still-neutral-on-shares/97209#comments Mon, 02 Apr 2012 17:37:02 +0000 vitalstocks http://www.stockbloghub.com/?p=97209 http://www.stockbloghub.com/2012/04/02/hgsi-human-genome-sciences-analyst-still-neutral-on-shares/97209/feed 0 http://www.stockbloghub.com/2011/12/29/jnj-pharma-biotech-stock-review-outlook-industry-outlook/89365 http://www.stockbloghub.com/2011/12/29/jnj-pharma-biotech-stock-review-outlook-industry-outlook/89365#comments Thu, 29 Dec 2011 15:55:25 +0000 vitalstocks http://www.stockbloghub.com/?p=89365 http://www.stockbloghub.com/2011/12/29/jnj-pharma-biotech-stock-review-outlook-industry-outlook/89365/feed 0 http://www.stockbloghub.com/2011/12/08/alny-alnylam-pharmaceuticals-analyst-still-bullish/88197 http://www.stockbloghub.com/2011/12/08/alny-alnylam-pharmaceuticals-analyst-still-bullish/88197#comments Thu, 08 Dec 2011 17:05:51 +0000 vitalstocks http://www.stockbloghub.com/?p=88197 http://www.stockbloghub.com/2011/12/08/alny-alnylam-pharmaceuticals-analyst-still-bullish/88197/feed 0 http://www.stockbloghub.com/2011/12/07/eu-emerging-markets-the-way-forward/88206 http://www.stockbloghub.com/2011/12/07/eu-emerging-markets-the-way-forward/88206#comments Wed, 07 Dec 2011 21:57:17 +0000 vitalstocks http://www.stockbloghub.com/?p=88206 http://www.stockbloghub.com/2011/12/07/eu-emerging-markets-the-way-forward/88206/feed 0